Category Archives: Taxotere

Featured Stories

Bisphosphonate Study Confirms Atypical Thigh Fracture Risk

New research has confirmed the link between bisphoshonates, such as Fosamax, and atypical femur fractures, a type of thigh fracture that occurs spontaneously, without any major leg injury. The study, published in the Archives of Internal Medicine, also found that the risk of atypical thigh fractures increases the longer a ...

Read More

Former Executives Accuse Health Technology Firm of Fraud

Former Executives Accuse Health Technology Firm of Fraud

Former NantHealth executives claim that the company made fraudulent claims about the reliability of its system, which links patient information gathered by the devices.

Read More

National Law Firms Calls for More FDA Action on Actos Bladder Cancer Threat

A national law firm is not satisfied with the way the U.S. Food & Drug Administration (FDA) has handled warnings regarding Actos (pioglitazone) bladder cancer risks. In a statement published today, Parker Waichman LLP called on the FDA to compel Takeda Pharmaceuticals, the maker of the type 2 diabetes drug, ...

Read More

Western Pennsylvania Familes File Suit Over Alleged Fracking Pollution

Three families in western Pennsylvania believe a leading hydraulic fracturing (fracking) company and two water testing labs are conspiring to produce false results that show natural gas drilling is not contaminating their private water wells.

Read More

Cancer Groups Issue Statement for Regulation of E-cigarettes

Cancer Groups Issue Statement Calling for Research and Regulation of E-cigarettes

The American Society of Clinical Oncology & the American Association for Cancer Research are calling on the government to regulate e-cigarettes.

Read More

DeflateGate’s Effects Impact Legal Gambling and the Economy

DeflateGate’s Effects Impact Legal Gambling and the Economy

The NFL has initiated a probe into the New England Patriots following allegations that the team intentionally used overly deflated footballs.

Read More

Majority of Metal-on-Metal Hip Implant Failures Occur within Two Years, Study Finds

A newly published metal-on-metal hip replacement study is reporting that the majority of failures occur early, within two years of surgery. The study, published in the journal Orthopedics, is just the latest to indicate that close follow-up of metal-on-metal hip implant patients is warranted.

Read More

Federal Judge Certifies Medtronic Infuse Shareholder Class Action Lawsuit

A shareholder lawsuit alleging Medtronic Inc. illegally promoted the off-label use of its Infuse bone growth product has been granted class action status by U.S. District Judge Paul Magnuson of Minnesota. According to a report from Law360.com, the Medtronic Infuse off-label promotion lawsuit was filed by several institutional investors on ...

Read More

Fracking Boom Changing Way of Life in Pennsylvania's Northern Tier

In just a few years, the impact of hydraulic fracturing (fracking) drilling on northeastern Pennsylvania is hard to miss. Thousands of natural gas wells have been opened in that area specifically in the last five years as companies look to exploit the vast Marcellus shale formation about two miles below the ...

Read More

Bayer Yaz, Yasmin Blood Clot Lawsuit Settlements Stand at $147 Million

Bayer AG reported yesterday that it continues to settle Yaz and Yasmin birth control pill lawsuits. According to a report from Bloomberg News, the company said in its latest Stockholder Newsletter that it has settled 651 Yaz and Yasmin blood clot lawsuits for a total of $147 million. The average ...

Read More

Woman Alleges Permanent Alopecia after Using Taxotere Chemotherapy Drug

Woman Alleges Permanent Alopecia after Using Taxotere

Sanofi-Aventis is facing another lawsuit over its chemotherapy drug, Taxotere. A woman alleges that the company failed to warn about the risk of permanent alopecia, or hair loss, after taking Taxotere. She alleges that the company misled her and her … Continue reading

Posted in Pharmaceuticals, Taxotere | Tagged , , , , |

New Lawsuit Filed over Taxotere Alleges Permanent Hair Loss

New Lawsuit Filed over Taxotere Alleges Permanent Hair Loss

Sanofi-Aventis is facing a new lawsuit filed over Taxotere, a chemotherapy drug used to treat breast cancer and other forms of cancer. The suit, filed on behalf of a Mississippi woman, alleges that the drug resulted in alopecia, or permanent … Continue reading

Posted in Pharmaceuticals, Taxotere | Tagged , , , , , , |

Lawsuits Filed when Permanent Chemotherapy Hair Loss is Linked to Taxotere

Lawsuits Filed For Chemotherapy Hair Loss Link to Taxotere

Breast cancer patients are usually familiar with the likely side effect of chemotherapy of hair loss.  Most, however, expect that hair grows back once the chemotherapy is over. However, an increasing number of breast cancer patients are finding that this is … Continue reading

Posted in Health Concerns, Pharmaceuticals, Taxotere | Tagged , , , , , , |

Sanofi Faces Another Lawsuit over Taxotere

Sanofi Faces Another Lawsuit over Taxotere

Sanofi-Aventis faces another lawsuit alleging that its chemotherapy drug Taxotere led to permanent hair loss, or alopecia. The suit accuses the drug maker of failing to adequately warn about the risk of irreversible hair loss. The plaintiff is a California … Continue reading

Posted in Pharmaceuticals, Taxotere | Tagged , , , , , , , , , , , , |

© 2005-2018 Parker Waichman LLP ®. All Rights Reserved.